Acute Effects of Neurodynamics on Strength and Endurance in Athletes

July 20, 2026 updated by: Tommy Wyatt, High Point University

Acute Effects of Neurodynamics on Strength and Endurance in Athletes: A Randomized Control Trial

This study explores the acute effects of neurodynamics, an intervention commonly used by physical therapist to improve nerve mobility and decrease pain, on the strength and muscular endurance in the athletic population. This study aims to find if these interventions can maintain or promote strength and endurance in the hamstrings. The studies results will help physical therapist better prescribe exercise and hands-on treatment for hamstring and sciatic nerve related conditions and injuries.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

45

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • North Carolina
      • High Point, North Carolina, United States, 27268
        • Recruiting
        • High Point University
        • Contact:
        • Principal Investigator:
          • Tommy Wyatt, DPT

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Participants must be between 18 and 30 years of age.
  • Must be able to read, understand, and provide informed consent, in English.
  • Must be currently participating in an organized sport (e.g. collegiate, club, or competitive recreational level) or engaging in structured resistance training and athletic conditioning for recreational sports events (e.g 5k, marathon, Crossfit, Hyrox, etc).
  • Medically stable with no known contraindications to physical exertion.
  • Cleared for participation in strength or maximal-effort isometric testing.
  • Be able to perform lower extremity isometric testing without pain that limits maximal effort.
  • Must have 2 lower extremities capable to producing full range knee flexion and extension range of motion.
  • No medical condition that significantly alters lower extremity neuromuscular performance.
  • No history of lower extremity surgery in the past 12 months.

Exclusion Criteria:

  • Individuals younger than 18 or older than 30.
  • Acute lower extremity injury in the last 12 weeks.
  • Lower extremity surgery within the last 12 months.
  • Pain in either lower extremity that would limit maximal physical exertion.
  • History of neurological disorders, including but not limited to: Neuropathy, Stoke, MS, Parkinson's Disease, etc.
  • Use of medications that significantly impact neuromuscular performance, strength or fatigue.
  • No supplementation that affects neuromuscular performance, strength, or fatigue.
  • Unable to read and understand English.
  • Not in a vulnerable population: Pregnant, mentally or physically challenged, cognitively impaired.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Sliders
Manually applying slider technique of neurodynamics.
Mobility of a nerve, by placing tension on one end of the nerve and slacking (removing) tension off the other side of the nerve, through a full range of motion.
Active Comparator: Tensioners
Manually applied tensioner, neurodynamic technique
Loading the nerve, by placing tension on both ends of the nerve, isometrically at end range of motion.
Experimental: Mechanically Loaded Neurodynamics
Externally loaded neurodynamic intervention in the slider technique.
Placing tension on one end of the nerve while taking the tension off the other end, under external load of an elastic resistance band.
Elastic resistance band was used to provide submaximal resistance during the mechanically loaded neurodynamic intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Isometric Strength
Time Frame: From initial strength and endurance test, to the post intervention strength and endurance test, assessed during a single study visit, assessed up to 30 minutes.
Isometric strength of the hamstrings in knee flexion.
From initial strength and endurance test, to the post intervention strength and endurance test, assessed during a single study visit, assessed up to 30 minutes.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Endurance Ratio (isokinetic)
Time Frame: From initial endurance test to post intervention endurance test, during a single study visit, assessed up to 30 minutes.
Endurance ratio of knee flexion, measured isokinetically.
From initial endurance test to post intervention endurance test, during a single study visit, assessed up to 30 minutes.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tommy Wyatt, DPT, High PointUniversity

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 15, 2026

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

July 1, 2026

Study Registration Dates

First Submitted

July 16, 2026

First Submitted That Met QC Criteria

July 20, 2026

First Posted (Actual)

July 22, 2026

Study Record Updates

Last Update Posted (Actual)

July 22, 2026

Last Update Submitted That Met QC Criteria

July 20, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The raw pre and post isometric and isokinetic endurance ratio data for each participant will be shared. Along with the intervention leg, testing order, intervention provided, level of athletic participation, primary sport activity, age, sex.

IPD Sharing Time Frame

From study end date, for 3 years following.

IPD Sharing Access Criteria

Yes, individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices), will be shared. Information will be available to researchers who provide a methodologically sound proposal to achieve aims in the approved proposal. Data will be available beginning 3 months and ending 36 months following article publication. Supporting documents including the study protocol and statistical analysis plan will also be available. Requests should be directed to twyatt2@highpoint.edu

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lumbar Disc Herniation

Clinical Trials on Sciatic Slider

3
Subscribe